Transcriptional Regulation of Rat Cyclin D1 Gene by CpG Methylation Status in Promoter Region*

Cyclin D1, a G1/S cell cycle-regulating oncogene, is known to be transcriptionally regulated by numerous growth factors. We cloned and characterized the rat cyclin D1 gene 5′-flanking region and, by species- and subspecies-matched transient transfection studies, found that a basic promoter structure with a cAMP response element and two continuous Sp1-binding sites was crucial for the steady-state expression of the cyclin D1 gene. Furthermore, the methylation status especially around two continuous Sp1-binding sites was found to be an important epigenetical mechanism determining the steady-state expression level in rat leukemic cell lines K4D, K4DT, and K4D16. Whether or not epigenetic control of the cyclin D1 gene existed among normal rat tissues was further examined by high sensitivity mapping of the methylated cytosine. In normal rat tissues, the methylated cytosines at non-CpG loci within two continuous Sp1-binding sites were observed in uterine stromal cells of the basal layer and found to be demethylated in the functioning layer, possibly by a passive demethylation mechanism through cell division. Since in the passive demethylation process Sp1-binding sites remain methylated in a part of the cell population, methylated cytosines at Sp1-binding sites may be essential for keeping a number of the stromal cells in the basal layer live against estrogen-induced proliferation that leads to either apoptosis or compaction.

[1]  S. Maeda,et al.  Establishment and chromosome studies of in vitro lines of chemically induced rat erythroblastic leukemia cells. , 1980, Journal of the National Cancer Institute.

[2]  G. Peters,et al.  Expression of cyclin D2 in Epstein-Barr virus-positive Burkitt's lymphoma cell lines is related to methylation status of the gene , 1995, Journal of virology.

[3]  J. Bartek,et al.  Cyclin D1 expression is regulated by the retinoblastoma protein. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[4]  A. Olek,et al.  A modified and improved method for bisulphite based cytosine methylation analysis. , 1996, Nucleic acids research.

[5]  J. Benítez,et al.  Loss of p16/INK4A protein expression in non-Hodgkin's lymphomas is a frequent finding associated with tumor progression. , 1998, The American journal of pathology.

[6]  K. Tamura,et al.  Cyclin G: a new mammalian cyclin with homology to fission yeast Cig1. , 1993, Oncogene.

[7]  A. Bird,et al.  Purification, sequence, and cellular localization of a novel chromosomal protein that binds to Methylated DNA , 1992, Cell.

[8]  A. Rustgi,et al.  Transforming growth factor-alpha enhances cyclin D1 transcription through the binding of early growth response protein to a cis-regulatory element in the cyclin D1 promoter. , 1997, The Journal of biological chemistry.

[9]  E. E. Brooks,et al.  Functional Analysis of the Human Cyclin D2 and Cyclin D3 Promoters (*) , 1996, The Journal of Biological Chemistry.

[10]  J. Herman,et al.  Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer , 1999, Nature Genetics.

[11]  P. Chomet,et al.  Cytosine methylation in gene-silencing mechanisms. , 1991, Current opinion in cell biology.

[12]  Richard A. Ashmun,et al.  Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle , 1991, Cell.

[13]  S. Clark,et al.  Sp1 binding is inhibited by mCpmCpG methylation , 1997 .

[14]  J. Herman,et al.  Distinct patterns of inactivation of p15INK4B and p16INK4A characterize the major types of hematological malignancies. , 1997, Cancer research.

[15]  D. Tindall,et al.  Epidermal growth factor induces cyclin D1 in a human prostate cancer cell line , 1998, The Prostate.

[16]  R. Pestell,et al.  Identification of the cyclin D1 gene as a target of activating transcription factor 2 in chondrocytes. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[17]  S. Shurtleff,et al.  Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts. , 1993, Genes & development.

[18]  Ruth J. Muschel,et al.  Cell Cycle-dependent Regulation of the Cyclin B1 Promoter (*) , 1995, The Journal of Biological Chemistry.

[19]  E. Ziff,et al.  Nerve Growth Factor Induces Transcription of the p21 WAF1/CIP1 and Cyclin D1 Genes in PC12 Cells by Activating the Sp1 Transcription Factor , 1997, The Journal of Neuroscience.

[20]  L. E. McDonald,et al.  A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[21]  A. Razin,et al.  DNA Demethylation In Vitro: Involvement of RNA , 1996, Cell.

[22]  S. Kudo.  Methyl-CpG-Binding Protein MeCP2 Represses Sp1-Activated Transcription of the Human Leukosialin Gene When the Promoter Is Methylated , 1998, Molecular and Cellular Biology.

[23]  L. Zon,et al.  Induction of cyclin D1 by simian virus 40 small tumor antigen. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[24]  R. Kitazawa,et al.  Promoter structure of human sonic hedgehog gene. , 1998, Biochimica et biophysica acta.

[25]  Richard J. Lee,et al.  Angiotensin II Activation of Cyclin D1-dependent Kinase Activity* , 1996, The Journal of Biological Chemistry.

[26]  A. Razin,et al.  Methylation changes in the apolipoprotein AI gene during embryonic development of the mouse. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[27]  R. Sutherland,et al.  Estrogen-induced Activation of Cdk4 and Cdk2 during G1-S Phase Progression Is Accompanied by Increased Cyclin D1 Expression and Decreased Cyclin-dependent Kinase Inhibitor Association with Cyclin E-Cdk2* , 1997, The Journal of Biological Chemistry.

[28]  A. Arnold,et al.  PRAD1/lCyclin D1 proto‐oncogene: Genomic organization, 5′ dna sequence, and sequence of a tumor‐specific rearrangement breakpoint , 1993 .

[29]  Charles J. Sherr,et al.  Mammalian G1 cyclins , 1993, Cell.

[30]  D. Eick,et al.  Structure and cell cycle-regulated transcription of the human cyclin A gene. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[31]  R. Weinberg,et al.  Regulation of retinoblastoma protein functions by ectopic expression of human cyclins , 1992, Cell.

[32]  C. D. Edwards,et al.  A novel p16INK4A transcript. , 1995, Cancer research.

[33]  Chris Albanese,et al.  Inhibition of Cyclin D1 Kinase Activity Is Associated with E2F-Mediated Inhibition of Cyclin D1 Promoter Activity through E2F and Sp1 , 1998, Molecular and Cellular Biology.

[34]  I. Weinstein,et al.  Amplification and expression of the human cyclin D gene in esophageal cancer. , 1992, Cancer research.

[35]  A. Razin,et al.  Tissue-specific methylation patterns and expression of the human apolipoprotein AI gene. , 1990, Journal of Biological Chemistry.

[36]  David O. Morgan,et al.  Principles of CDK regulation , 1995, Nature.

[37]  S. Kitazawa,et al.  Interleukin-4 Induces Expression of the Integrin αvβ3 via Transactivation of the β3 Gene (*) , 1995, The Journal of Biological Chemistry.

[38]  J. Herman,et al.  Hypermethylation-associated inactivation indicates a tumor suppressor role for p15INK4B. , 1996, Cancer research.

[39]  M W Simmen,et al.  Nonmethylated transposable elements and methylated genes in a chordate genome. , 1999, Science.

[40]  A. Bird,et al.  The methyl-CpG binding protein MeCP2 is essential for embryonic development in the mouse , 1996, Nature Genetics.

[41]  M. Beato,et al.  Inducible regulatory elements in the human cyclin D1 promoter. , 1994, Oncogene.

[42]  C. Albanese,et al.  Transforming p21ras Mutants and c-Ets-2 Activate the Cyclin D1 Promoter through Distinguishable Regions (*) , 1995, The Journal of Biological Chemistry.

[43]  J. Silke,et al.  An embryonic demethylation mechanism involving binding of transcription factors to replicating DNA , 1998, The EMBO journal.

[44]  R. Weinberg,et al.  Physical interaction of the retinoblastoma protein with human D cyclins , 1993, Cell.

[45]  T. Serikawa,et al.  Alternative splicing of the erythropoietin receptor gene correlates with erythroid differentiation in rat hematopoietic and leukemic cells. , 1997, Cancer letters.